PA 1050040
Alternative Names: PA-040; PA-1050040Latest Information Update: 03 Apr 2009
At a glance
- Originator Panacos Pharmaceuticals Inc
- Class Antivirals
- Mechanism of Action Capsid protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 25 Jul 2007 Data presented at the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS-2007) added to the Viral Infections antimicrobial activity and pharmacokinetics sections
- 28 Feb 2007 Phase-I clinical trials in HIV infections treatment in USA (PO)
- 28 Dec 2006 Preclinical trials in HIV infections treatment in USA (unspecified route)